Frank Ruffo

Insider Reports History

Entity
Individual
Location
C/O Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Ruffo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Financial Officer Common Stock 202K $212K $1.05 Mar 10, 2022 Direct
Aclaris Therapeutics, Inc. Chief Financial Officer Restricted stock units 16.6K $17.4K $1.05 Mar 2, 2022 Direct
Aclaris Therapeutics, Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 155K Mar 1, 2022 Direct

Insider Reports Filed by Frank Ruffo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Mar 10, 2022 1 -$199K 4 Mar 14, 2022 Chief Financial Officer
ACRS Aclaris Therapeutics, Inc. Mar 1, 2022 8 $0 4 Mar 3, 2022 Chief Financial Officer
ACRS Aclaris Therapeutics, Inc. Feb 9, 2022 1 -$17.6K 4 Feb 11, 2022 Chief Financial Officer
ACRS Aclaris Therapeutics, Inc. Feb 1, 2022 2 $0 4 Feb 3, 2022 Chief Financial Officer
ACRS Aclaris Therapeutics, Inc. Jun 1, 2021 4 -$325K 4 Jun 2, 2021 Chief Financial Officer